Lead sponsor
Cassava Sciences, Inc.
6 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
6
Trials led
0
Ongoing
3,384
Total enrollment
214
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
3
Phase 3
3
Trials by status
Completed
3
Terminated
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's DiseaseAge ≥50Ph 2Terminated90